Actinium Pharmaceuticals, Inc.·4

Feb 21, 4:45 PM ET

SETH SANDESH 4

4 · Actinium Pharmaceuticals, Inc. · Filed Feb 21, 2019

Insider Transaction Report

Form 4
Period: 2019-02-21
SETH SANDESH
Director
Transactions
  • Exercise of In-Money

    Common Stock

    2019-02-21$0.60/sh+8,125$4,875161,458 total

Documents

1 file
  • 4
    ownership.xmlPrimary